• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Align Technology Inc.

    8/6/25 4:27:27 PM ET
    $ALGN
    Industrial Specialties
    Health Care
    Get the next $ALGN alert in real time by email
    S-8 1 forms-8x20250806.htm S-8 Document
    As filed with the Securities and Exchange Commission on August 6, 2025

    Registration No. 333-

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933


    ALIGN TECHNOLOGY, INC.
    (Exact name of registrant as specified in its charter)
    Delaware94-3267295
    (State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)


    410 North Scottsdale Road, Suite 1300 Tempe, Arizona 85288
    (Address of Principal Executive Offices) (Zip Code)

    Align Technology, Inc. 2005 Incentive Plan
    (Full title of the plan)

    Julie Coletti
    Executive Vice President, Chief Legal and Regulatory Officer
    410 North Scottsdale Road, Suite 1300
    Tempe, Arizona 85288
    (Name and address of agent for service)

    (602) 742-2000
    (Telephone number, including area code, of agent for service)

    Copy to:
    Katharine A. Martin
    Lauren B. Lichtblau
    Wilson Sonsini Goodrich & Rosati, P.C.
    650 Page Mill Road
    Palo Alto, California 94304
    (650) 493-9300

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer☒Accelerated filer☐
    Non-accelerated filer☐Smaller reporting company☐
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐




    EXPLANATORY NOTE

    In May 2005, the stockholders of Align Technology, Inc., a Delaware corporation (the “Company”), approved the Align Technology, Inc. 2005 Incentive Plan (as amended to date, the “2005 Plan”). In May 2025, the Company’s stockholders approved an amendment to the 2005 Plan solely to increase the number of shares of common stock, $0.0001 par value per share (“Common Stock”), reserved for issuance under the 2005 Plan by 2,500,000 shares (the “Additional Shares”). As a result, the aggregate number of shares of Common Stock reserved for issuance under the 2005 Plan is 34,668,895.

    The Additional Shares are securities of the same class as other securities for which Registration Statements on Form S-8 relating to the 2005 Plan were previously filed with the Securities and Exchange Commission (the “SEC”) on June 7, 2005 (File No. 333-125586), May 25, 2006 (File No. 333-134477), May 29, 2007 (File No. 333-143319), August 5, 2009 (File No. 333-161054), August 5, 2010 (File No. 333-168548), August 8, 2011 (File No. 333-176134), August 2, 2013 (File No. 333-190351), November 8, 2016 (File No. 333-214493) and August 4, 2023 (File No. 333-273715) (the “Prior Registration Statements”). Pursuant to General Instruction E of Form S-8, the Prior Registration Statements are incorporated by reference into this Registration Statement on Form S-8 (the “Registration Statement”).

    In accordance with the instructional note to Part I of Form S-8 as promulgated by the SEC, the information specified by Part I of Form S-8 has been omitted from this Registration Statement.




    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3.        Incorporation of Documents by Reference.

    The following documents previously filed with the SEC are incorporated by reference into this Registration Statement:

    (a)    the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on February 28, 2025 (the “Annual Report”), including the information specifically incorporated by reference into the Annual Report from the Company’s Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 8, 2025;

    (b)    the Company’s Quarterly Reports on Form 10-Q for the quarter ended March 31, 2025, filed with the SEC on May 8, 2025, and for the quarter ended June 30, 2025, filed with the SEC on August 6, 2025;

    (c)    the Company’s Current Reports on Form 8-K filed with the SEC on May 21, 2025 and July 2, 2025; and

    (d)    the description of the Common Stock contained in the Company’s Registration Statement on Form 8-A (File No. 000-32259), filed with the SEC on January 25, 2001, including any amendments or reports filed for the purpose of updating this description, including Exhibit 4.2 to the Annual Report.

    All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the SEC shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration



    Statement to the extent that a statement contained herein or in any other subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

    Item 8.        Exhibits.

    Exhibit NumberDescription
    4.1
    Align Technology, Inc. 2005 Incentive Plan (as amended on May 21, 2025) (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 21, 2025)
    5.1*
    Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation
    23.1*
    Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (contained in Exhibit 5.1 hereto)
    23.2*
    Consent of Pricewaterhouse Coopers LLP, Independent Registered Public Accounting Firm
    24.1*
    Power of Attorney (contained in signature page)
    107*
    Calculation of Filing Fee Tables
    * Filed herewith.    
        

    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Tempe, State of Arizona, on the 6th day of August 2025.
    ALIGN TECHNOLOGY, INC.
    By:/s/ Julie Coletti
    Julie Coletti
    Executive Vice President, Chief Legal and Regulatory Officer




    POWER OF ATTORNEY

    Each person whose signature appears below hereby constitutes and appoints, jointly and severally, Julie Coletti and Joseph M. Hogan as her or his attorney-in-fact, each with full power of substitution and resubstitution, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact, or her or his substitute or substitutes, may do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated:




    Signature  Title Date
    /s/    JOSEPH M. HOGAN
      
    President, Chief Executive Officer and Director (Principal Executive Officer)
     August 6, 2025
    Joseph M. Hogan
    /s/    JOHN F. MORICI
      
    Chief Financial Officer and Executive Vice President, Global Finance (Principal Financial Officer and Principal Accounting Officer)
     August 6, 2025
    John F. Morici
    /s/    KEVIN T. CONROY
    DirectorAugust 6, 2025
    Kevin T. Conroy
    /s/    JOSEPH LACOB 
    DirectorAugust 6, 2025
    Joseph Lacob
    /s/    C. RAYMOND LARKIN, JR.     
      
    Chairman of the Board
     August 6, 2025
    C. Raymond Larkin, Jr.
    /s/    GEORGE J. MORROW    
      Director August 6, 2025
    George J. Morrow
    /s/    ANNE M. MYONG      
    DirectorAugust 6, 2025
    Anne M. Myong
    /s/   MOJDEH POUL
    DirectorAugust 6, 2025
    Mojdeh Poul
    /s/    ANDREA L. SAIA
    DirectorAugust 6, 2025
    Andrea L. Saia
    /s/    SUSAN E. SIEGEL 
    DirectorAugust 6, 2025
    Susan E. Siegel




    Get the next $ALGN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALGN

    DatePrice TargetRatingAnalyst
    7/31/2025$154.00Overweight → Equal-Weight
    Morgan Stanley
    4/25/2025$170.00Buy → Hold
    HSBC Securities
    2/14/2025$255.00Overweight
    Wells Fargo
    1/6/2025$235.00 → $280.00Market Perform → Outperform
    Leerink Partners
    12/4/2024$295.00Outperform
    Mizuho
    10/10/2024Hold
    Needham
    2/26/2024$310.00Market Perform
    Leerink Partners
    12/11/2023$197.00Neutral → Sell
    Goldman
    More analyst ratings

    $ALGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Director Larkin C Raymond Jr bought $1,529,645 worth of shares (6,500 units at $235.33) and gifted 4,650 shares, increasing direct ownership by 9% to 23,597 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/19/24 6:35:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    SEC Filings

    View All

    SEC Form S-8 filed by Align Technology Inc.

    S-8 - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    8/6/25 4:27:27 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form 10-Q filed by Align Technology Inc.

    10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    8/6/25 4:07:34 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    8/4/25 8:32:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Vitalone Britt J.

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    7/7/25 4:13:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $ALGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Align Tech downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Align Tech from Overweight to Equal-Weight and set a new price target of $154.00

    7/31/25 7:16:13 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Tech downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Align Tech from Buy to Hold and set a new price target of $170.00

    4/25/25 8:29:20 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Wells Fargo initiated coverage on Align Tech with a new price target

    Wells Fargo initiated coverage of Align Tech with a rating of Overweight and set a new price target of $255.00

    2/14/25 7:02:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Initiates Patent Infringement Ligitation Against Angelalign Technology

    Enforces patents representing critical components of its broad intellectual property portfolio and reflecting key investments and innovations in clear aligner therapy, including multilayer aligner material, cutting-edge treatment planning, and advanced aligner features Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the filing of patent infringement lawsuits against Angelalign Technology, Inc. ("Angel") (Hong Kong Stock Exchange: 6699.HK), a Shangha

    8/18/25 6:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Announces $200 Million Open Market Repurchase

    Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $200 million of Align's common stock through open market repurchases under Align's $1.0 billion stock repurchase program that was approved by Align's Board of Directors in April 2025. "We are pleased to announce our intention to repurchase $200 million of our common stock through open market transactions. This decision reflects the continued confidence of management and

    8/5/25 8:30:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align's Common Stock

    Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of Align's common stock. Since his last sale of Align common stock in 2021, Mr. Hogan has purchased approximately $8 million of Align common stock1. "This purchase reflects my continuing confidence in the long-term value of Align and our commitment to increasing shareholder value by balancing investment

    8/1/25 6:57:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Financials

    Live finance-specific insights

    View All

    Align Technology Announces Second Quarter 2025 Financial Results

    Q2'25 total revenues were $1,012.4 million, up 3.4% sequentially and down 1.6% year-over-year Q2'25 total revenues were favorably impacted by foreign exchange by approximately $26.4 million, or 2.7% sequentially, and favorably impacted by approximately $5.6 million, or 0.6% year-over-year(1) Q2'25 Clear Aligner revenues were $804.6 million, up 1.0% sequentially and down 3.3% year-over-year Q2'25 Clear Aligner volume was 644.4 thousand cases, up 0.3% sequentially and year-over-year Q2'25 Imaging Systems and CAD/CAM Services revenues were $207.8 million, up 13.9% sequentially and up 5.6% year-over-year Q2'25 operating income of $163.0 million and operating margin of 16.1%, non

    7/30/25 4:14:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology to Announce Second Quarter 2025 Results on July 30, 2025

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2025 financial results on Wednesday, July 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

    7/1/25 8:30:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Announces First Quarter 2025 Financial Results

    Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by

    4/30/25 4:15:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Leadership Updates

    Live Leadership Updates

    View All

    Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

    Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are

    3/25/25 4:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res

    5/22/24 5:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Appoints Karim Boussebaa, EVP and MD of iTero Scanner and Services Business—Yuval Shaked to Leave Align End of 2023

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition

    2/8/23 4:55:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/13/24 4:59:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/24 4:31:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/23 11:07:31 AM ET
    $ALGN
    Industrial Specialties
    Health Care